Mackenzie Financial’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,138
| Closed | -$39.5K | – | 1558 |
|
|
2024
Q1 | $39.5K | Sell |
18,138
-1,541
| -8% | -$3.36K | ﹤0.01% | 1490 |
|
|
2023
Q4 | $30.5K | Buy |
19,679
+4,042
| +26% | +$6.27K | ﹤0.01% | 1473 |
|
|
2023
Q3 | $19.4K | Buy |
+15,637
| New | +$19.4K | ﹤0.01% | 1452 |
|
|
2023
Q1 | – | Sell |
-15,639
| Closed | -$25K | – | 1536 |
|
|
2022
Q4 | $25K | Hold |
15,639
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q3 | $23K | Hold |
15,639
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q2 | $29K | Buy |
15,639
+2,399
| +18% | +$4.45K | ﹤0.01% | 1419 |
|
|
2022
Q1 | $35K | Buy |
+13,240
| New | +$35K | ﹤0.01% | 1380 |
|